6H9I

Csf5, CRISPR-Cas type IV Cas6 crRNA endonuclease

6H9I の概要

• エントリーDOI: 10.2210/pdb6h9i/pdb
• 分子名称: Csf5, crRNA, L(+)-TARTARIC ACID, ... (6 entities in total)
• 機能のキーワード: type iv crispr-cas, crrna biogenesis, endonuclease, rna binding protein
• 由来する生物種: Aromatoleum aromaticum (strain EbN1) (Azoarcus sp. (strain EbN1)); 詳細
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 76322.99

構造登録者

Pausch, P.,Bange, G. (登録日: 2018-08-04, 公開日: 2018-09-26, 最終更新日: 2024-01-17)

主引用文献

Ozcan, A.,Pausch, P.,Linden, A.,Wulf, A.,Schuhle, K.,Heider, J.,Urlaub, H.,Heimerl, T.,Bange, G.,Randau, L.
Type IV CRISPR RNA processing and effector complex formation in Aromatoleum aromaticum.
Nat Microbiol, 4:89-96, 2019

PubMed Abstract: Type IV CRISPR-Cas modules belong to class 1 prokaryotic adaptive immune systems, which are defined by the presence of multisubunit effector complexes. They usually lack the known Cas proteins involved in adaptation and target cleavage, and their function has not been experimentally addressed. To investigate RNA and protein components of this CRISPR-Cas type, we located a complete type IV cas gene locus and an adjacent CRISPR array on a megaplasmid of Aromatoleum aromaticum EbN1, which contains an additional type I-C system on its chromosome. RNA sequencing analyses verified CRISPR RNA (crRNA) production and maturation for both systems. Type IV crRNAs were shown to harbour unusually short 7 nucleotide 5'-repeat tags and stable 3' hairpin structures. A unique Cas6 variant (Csf5) was identified that generates crRNAs that are specifically incorporated into type IV CRISPR-ribonucleoprotein (crRNP) complexes. Structures of RNA-bound Csf5 were obtained. Recombinant production and purification of the type IV Cas proteins, together with electron microscopy, revealed that Csf2 acts as a helical backbone for type IV crRNPs that include Csf5, Csf3 and a large subunit (Csf1). Mass spectrometry analyses identified protein-protein and protein-RNA contact sites. These results highlight evolutionary connections between type IV and type I CRISPR-Cas systems and demonstrate that type IV CRISPR-Cas systems employ crRNA-guided effector complexes.

PubMed: 30397343
DOI: 10.1038/s41564-018-0274-8

実験手法

X-RAY DIFFRACTION (2.29 Å)